Related Experiment Video
Updated: Jan 17, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
A case report of a multivessel coronary vasospasm that responded to IV diazepam
Fares Abboud1, Mustafa Zain2, Ahmad Alsaadi2
1Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic.
Insights
Intravenous diazepam effectively treated multivessel coronary artery vasospasm (CAVS) unresponsive to standard treatments, particularly when linked to psychological stress. This case highlights a potential new therapy for refractory CAVS.
Area of Science:
- Cardiology
- Pharmacology
- Psychosomatic Medicine
Background:
- Coronary artery vasospasm (CAVS) can mimic coronary artery disease, leading to unnecessary interventions.
- Psychological stress is increasingly recognized as a factor in cardiovascular events.
Purpose of the Study:
- To report the efficacy of intravenous (IV) diazepam in managing multivessel CAVS.
- To explore the role of psychological stress in CAVS refractory to standard vasodilators.
Main Methods:
- A case report of a 32-year-old male with multivessel CAVS unresponsive to intracoronary nitroglycerin and verapamil.
- Administration of 5 mg IV diazepam during a panic attack.
- Repeat coronary angiography to assess treatment response.
Main Results:
- IV diazepam administration led to complete symptom resolution.
- Repeat angiography showed normal coronary arteries, with no evidence of plaques or stenosis.
- The patient's response occurred during a panic attack, suggesting a link to psychological stress.
Conclusions:
- Multivessel CAVS refractory to standard vasodilators can be effectively treated with IV diazepam.
- Psychological stress may play a significant role in CAVS, and benzodiazepines could be a therapeutic option.
- Further research is needed to confirm the efficacy of IV diazepam and explore the stress-CAVS connection.
Rationale:
Coronary artery vasospasm (CAVS) is a significant cause of acute chest syndrome, often mimicking coronary artery disease on angiography, which may lead to unnecessary interventions like percutaneous coronary intervention or coronary artery bypass grafting. This case report aims to highlight the potential therapeutic role of intravenous (IV) diazepam in managing multivessel CAVS unresponsive to standard vasodilators, emphasizing the influence of psychological stress in such cases.
Patient Concerns:
A 32-year-old male, a heavy smoker with a history of anxiety disorder and no familial coronary artery disease history, presented with angina.
Diagnoses:
Initial evaluations, including electrocardiogram, echocardiogram, and laboratory tests, were normal, but an exercise stress electrocardiogram was positive. Coronary angiography revealed severe lesions in the proximal left anterior descending and right coronary artery diagnosing multivessel CAVS.
Interventions:
The patient was unresponsive to intracoronary nitroglycerin and verapamil. During a panic attack in the procedure, 5 mg IV diazepam was administered.
Outcomes:
Treatment lead to symptom resolution and normal coronary arteries on repeat angiography, without plaques or stenosis.
Lessons:
This case demonstrates multivessel CAVS refractory to standard vasodilators but responsive to IV diazepam, as evidenced by angiographic resolution. The temporal association with a panic attack suggests a link to psychological stress, aligning with literature on stress-related cardiovascular events. Limitations include the single-case design, lack of provocation testing, and inability to definitively establish causality between anxiety and vasospasm, necessitating larger studies to confirm IV diazepam's efficacy. Multivessel CAVS may respond to IV diazepam when standard treatments fail, particularly in cases associated with psychological stress. This case underscores the need for further research to validate the therapeutic potential of IV benzodiazepines in managing CAVS and to explore the interplay between psychological stress and cardiovascular events.
Related Concept Videos
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Coronary Artery Disease V: Interprofessional Care
Vascular Spasm
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Drug Delivery: Enteral Route

